-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2024 to Q1 2025.
- Inhibrx Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $99.8M, a 158% increase year-over-year.
- Inhibrx Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $71.7M, a 64.5% decline from 2023.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)